Atlas Trials

Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS)

Clinical trial NCT02093429 · TERMINATED

Trial details

NCT number
NCT02093429
Sponsor
Incyte Corporation
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
MDS (Myelodysplastic Syndrome)
Start date
2014-01-01
Primary completion
2014-09-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.